欢迎您!
东篱公司
退出
申报数据库
申报指南
立项数据库
成果数据库
期刊论文
会议论文
著 作
专 利
项目获奖数据库
位置:
成果数据库
>
期刊
> 期刊详情页
Biomimetic enzyme nanocomplexes and their use as antidotes and preventive measures for alcohol
ISSN号:1748-3387
期刊名称:Nature Nanotechnology
时间:2013.3
页码:187-192
相关项目:特种药物
作者:
Liang, Sheng|Wei, Wei|Wang, Hui|Li, Jianmin|Zhu, Xinyuan|Shi, Linqi|Chen, Wei|Ji, Cheng|Lu, Yunfeng|
同期刊论文项目
特种药物
期刊论文 33
著作 1
同项目期刊论文
Overexpression of survivin and cyclin D1 in CHO cells confers apoptosis resistance and enhances grow
Enhanced expression of soluble recombinant tetanus neurotoxin Hc in Escherichia coli as a tetanus va
Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein exp
A Conformational Change of C Fragment of Tetanus Neurotoxin Reduces Its Ganglioside-Binding Activity
炭疽杆菌检测方法的研究现状与展望
单个B细胞抗体制备技术及应用
Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with
Intramuscular delivery of adenovirus serotype 5 vector expressing humanized protective antigen
Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus HBx
利用细胞毒性实验检测血液中炭疽毒素致死因子的方法学研究
结核分枝杆菌ESX-1分泌蛋白ESAT-6增强巨噬细胞吞噬功能
人破伤风基因工程中和抗体的研究进展
通过共表达转铁蛋白和细胞周期蛋白D1改造CHO细胞株
Establishment of Tetracycline-Inducible, Survivin-Expressing CHO Cell Lines by an Optimized Screenin
Antiviral Potential of Exogenous Human Omega Interferon to Inhibit Pandemic 2009A (H1N1) Influenza V
Intracellular delivery of artificial transcription factors fused to the protein transduction domain
Preparation of CHO cell-derived rhIFN-omega-Fc with improved pharmacokinetics
Prediction and identification of mouse cytotoxic T lymphocyte epitopes in Ebola virus glycoprot
Deletion modification enhances anthrax specific immunity and protective efficacy of a hepatitis B co
Secretory expression and efficient purification of recombinant anthrax toxin lethal factor with full
人破伤风免疫噬菌体单链抗体库的构建及体外亲和筛选
人源抗破伤风毒素单链二硫键稳定抗体的重组设计与表达
Creation of a six-fingered artificial transcription factor that represses the hepatitis B virus
炭疽的特异性治疗药物的研究进展